Hodgkin lymphoma in pregnancy - PubMed (original) (raw)

Hodgkin lymphoma in pregnancy

Veronika Bachanova et al. Curr Hematol Malig Rep. 2013 Sep.

Abstract

The peak incidence of Hodgkin lymphoma (HL) coincides with reproductive years, and as many as 3 % of all HL patients present with concurrent pregnancy. The management of a pregnant patient with HL requires a multidisciplinary approach combining expertise in medical oncology, high-risk obstetrics, and neonatology, as well as effective communication with the patient and her family. The goal is to optimize the mother's chance of a cure while allowing for delivery of a healthy child. A pregnant patient with HL should be staged by clinical examination and judicious use of non-radiation imaging such as ultrasound, balancing the need for accurate disease assessment with the need to minimize invasive procedures. The treatment strategy is individualized to the symptoms, lymphoma stage, gestational age and the patients' wishes. Therapeutic options include treatment deferral or single-agent vinblastine with reservation of multi-agent chemotherapy until the second or third trimester for the small minority of patients with aggressive clinical presentation.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Recommended algorithm for treatment of pregnancy-associated Hodgkin lymphoma (HL) ABVD doxorubicin, bleomycin, vinblastine, dacarbazine

Similar articles

Cited by

References

    1. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189:1128–35. - PubMed
    1. Connors JM. Clinical manifestations and natural history of Hodgkin’s lymphoma. Cancer J. 2009;15:124–8. - PubMed
    1. Connors JM. Challenging problems: coincident pregnancy, HIV infection, and older age. Hematol Am Soc Hematol Educ Program. 2008:334–9. - PubMed
    1. Bachanova V, Connors JM. How is Hodgkin lymphoma in pregnancy best treated? ASH evidence-based review 2008. Hematol Am Soc Hematol Educ Program. 2008:33–4. - PubMed
    1. Zanotti-Fregonara P, Jan S, Taieb D, et al. Absorbed 18F-FDG dose to the fetus during early pregnancy. J Nucl Med. 2010;51:803–5. Impact of PET/CT imaging on pregnancy. - PubMed

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources